NRIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $2,219,676.58

Nurix Therapeutics Insider Trading History Chart

Nurix Therapeutics Share Price & Price History

^$10.24

▲ +0.44 (4.49%)

As of 04/17/2025 05:00 PM ET

Days: 30 | 90 | 365

Nurix Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/3/2025	Hans van Houte	CFO	Sell	5,825	$14.49	$84,404.25	33,724
1/30/2025	Gwenn Hansen	Insider	Sell	3,690	$19.85	$73,246.50	55,937
1/30/2025	Hans van Houte	CFO	Sell	2,811	$19.85	$55,798.35	39,549
11/1/2024	Hans van Houte	CFO	Sell	3,546	$24.28	$86,096.88	33,724
10/30/2024	Gwenn Hansen	Insider	Sell	3,437	$24.30	$83,519.10	50,670
10/30/2024	Hans van Houte	CFO	Sell	2,368	$24.30	$57,542.40	37,270
10/14/2024	Christine Ring	Insider	Sell	3,290	$25.00	$82,250.00	24,592
10/1/2024	Christine Ring	Insider	Sell	5,760	$22.23	$128,044.80	24,592
9/3/2024	Christine Ring	Insider	Sell	9,050	$24.94	$225,707.00	24,592
8/26/2024	Christine Ring	Insider	Sell	9,870	$25.01	$246,848.70	24,592
8/26/2024	Hans van Houte	CFO	Sell	20,000	$25.22	$504,400.00	31,002
8/1/2024	Christine Ring	Insider	Sell	5,760	$21.43	$123,436.80	24,592
8/1/2024	Hans van Houte	CFO	Sell	3,477	$21.45	$74,581.65	51,002
7/30/2024	Gwenn Hansen	Insider	Sell	3,408	$20.67	$70,443.36	45,150
7/30/2024	Hans van Houte	CFO	Sell	2,490	$20.67	$51,468.30	54,479
7/1/2024	Christine Ring	Insider	Sell	5,760	$20.81	$119,865.60	19,838
6/12/2024	Christine Ring	Insider	Sell	1,900	$17.01	$32,319.00	19,838
6/5/2024	Christine Ring	Insider	Sell	400	$17.00	$6,800.00	19,838
6/3/2024	Christine Ring	Insider	Sell	1,596	$17.01	$27,147.96	19,838
5/2/2024	Hans van Houte	CFO	Sell	3,499	$12.83	$44,892.17	68,333
4/30/2024	Gwenn Hansen	Insider	Sell	2,007	$12.04	$24,164.28	39,601
4/30/2024	Hans van Houte	CFO	Sell	1,387	$12.04	$16,699.48	71,832
2/16/2024	Hans van Houte	CFO	Sell	6,812	$10.02	$68,256.24	68,333
1/30/2024	Gwenn Hansen	Insider	Sell	2,334	$7.99	$18,648.66	36,402
1/30/2024	Hans van Houte	CFO	Sell	1,671	$7.99	$13,351.29	75,145
12/19/2023	Hans van Houte	CFO	Sell	10,906	$10.00	$109,060.00	75,471
10/31/2023	Christine Ring	Insider	Sell	1,232	$5.20	$6,406.40	15,263
10/31/2023	Hans van Houte	CFO	Sell	1,080	$5.20	$5,616.00	86,377
7/31/2023	Christine Ring	General Counsel	Sell	1,420	$9.65	$13,703.00	12,544
7/31/2023	Gwenn Hansen	Insider	Sell	1,884	$9.65	$18,180.60	29,955
7/31/2023	Hans van Houte	CFO	Sell	1,245	$9.65	$12,014.25	82,571
5/1/2023	Christine Ring	General Counsel	Sell	682	$9.88	$6,738.16	10,040
5/1/2023	Gwenn Hansen	Insider	Sell	1,136	$9.88	$11,223.68	26,632
5/1/2023	Hans van Houte	CFO	Sell	721	$9.88	$7,123.48	78,930
5/1/2023	Stefani Wolff	COO	Sell	342	$9.88	$3,378.96	6,113
1/30/2023	Christine Ring	General Counsel	Sell	848	$11.78	$9,989.44	7,261
1/30/2023	Gwenn Hansen	Insider	Sell	1,412	$11.78	$16,633.36	23,009
1/30/2023	Hans van Houte	CFO	Sell	924	$11.78	$10,884.72	76,765
1/30/2023	Stefani Wolff	COO	Sell	424	$11.78	$4,994.72	3,940
10/31/2022	Christine Ring	General Counsel	Sell	699	$12.88	$9,003.12	6,185
10/31/2022	Gwenn Hansen	Insider	Sell	1,165	$12.88	$15,005.20	21,214
10/31/2022	Hans van Houte	CFO	Sell	739	$12.88	$9,518.32	74,803
10/31/2022	Stefani Wolff	COO	Sell	350	$12.88	$4,508.00	3,402
8/1/2022	Christine Ring	General Counsel	Sell	712	$15.67	$11,157.04	4,615
8/1/2022	Gwenn Hansen	Insider	Sell	1,186	$15.67	$18,584.62	19,172
8/1/2022	Hans van Houte	CFO	Sell	752	$15.67	$11,783.84	72,656
8/1/2022	Stefani Wolff	COO	Sell	356	$15.67	$5,578.52	1,238
5/2/2022	Christine Ring	General Counsel	Sell	660	$11.75	$7,755.00	3,403
5/2/2022	Gwenn Hansen	Insider	Sell	1,098	$11.75	$12,901.50	17,151
5/2/2022	Hans van Houte	CFO	Sell	697	$11.75	$8,189.75	2,189
5/2/2022	Stefani Wolff	COO	Sell	330	$11.75	$3,877.50	632

See Full Table

SEC Filings (Institutional Ownership Changes) for Nurix Therapeutics (NASDAQ:NRIX)

Institutional Buying and Selling by Quarter

Nurix Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/17/2025	Exchange Traded Concepts LLC	9,145	$0.11M	0.0%	+38.9%	0.012%
4/8/2025	Rhumbline Advisers	110,488	$1.31M	0.0%	+7.0%	0.145%
4/7/2025	GAMMA Investing LLC	14,018	$0.17M	0.0%	+202.2%	0.018%
3/24/2025	Wellington Management Group LLP	3,586,605	$67.57M	0.0%	+3.0%	4.726%
2/19/2025	GF Fund Management CO. LTD.	1,487	$28K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	146,713	$2.76M	0.0%	+14.2%	0.193%
2/17/2025	Woodline Partners LP	338,462	$6.38M	0.0%	+0.5%	0.446%
2/17/2025	Velan Capital Investment Management LP	97,889	$1.84M	1.6%	N/A	0.129%
2/17/2025	Vestal Point Capital LP	485,000	$9.14M	0.5%	+14.1%	0.639%
2/17/2025	Soleus Capital Management L.P.	2,102,833	$39.62M	2.5%	+97.3%	2.771%
2/17/2025	Squarepoint Ops LLC	76,634	$1.44M	0.0%	+13.9%	0.101%
2/17/2025	Twinbeech Capital LP	29,776	$0.56M	0.0%	-54.5%	0.039%
2/17/2025	Two Sigma Advisers LP	79,100	$1.49M	0.0%	+33.8%	0.104%
2/17/2025	Two Sigma Investments LP	135,084	$2.55M	0.0%	+166.4%	0.178%
2/17/2025	Tema Etfs LLC	22,557	$0.43M	0.2%	N/A	0.030%
2/17/2025	Rafferty Asset Management LLC	116,186	$2.19M	0.0%	+24.1%	0.153%
2/17/2025	Redmile Group LLC	4,192,627	$78.99M	5.5%	-2.1%	5.525%
2/17/2025	Point72 Asset Management L.P.	872,959	$16.45M	0.0%	N/A	1.150%
2/17/2025	ProShare Advisors LLC	23,132	$0.44M	0.0%	+45.8%	0.030%
2/17/2025	Parkman Healthcare Partners LLC	532,172	$10.03M	1.3%	+21.2%	0.701%
2/17/2025	Patient Square Capital LP	446,296	$8.41M	3.1%	+37.0%	0.588%
2/17/2025	Nomura Holdings Inc.	10,514	$0.20M	0.0%	N/A	0.014%
2/17/2025	Nuveen Asset Management LLC	409,637	$7.72M	0.0%	-39.2%	0.540%
2/17/2025	Millennium Management LLC	424,137	$7.99M	0.0%	+91.3%	0.559%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	44,518	$0.84M	0.0%	+15.3%	0.059%
2/17/2025	Integral Health Asset Management LLC	250,000	$4.71M	0.4%	+25.0%	0.329%
2/17/2025	Jacobs Levy Equity Management Inc.	229,369	$4.32M	0.0%	N/A	0.302%
2/17/2025	Ensign Peak Advisors Inc	374,673	$7.06M	0.0%	+108.2%	0.494%
2/17/2025	Fred Alger Management LLC	168,762	$3.18M	0.0%	+1.7%	0.222%
2/17/2025	D. E. Shaw & Co. Inc.	112,841	$2.13M	0.0%	+54.9%	0.149%
2/17/2025	Deutsche Bank AG	531,197	$10.01M	0.0%	-37.8%	0.700%
2/17/2025	Driehaus Capital Management LLC	1,279,691	$24.11M	0.2%	-0.5%	1.686%
2/17/2025	Deep Track Capital LP	3,000,000	$56.52M	2.1%	-22.4%	3.953%
2/17/2025	Cubist Systematic Strategies LLC	124,025	$2.34M	0.0%	N/A	0.163%
2/17/2025	Brevan Howard Capital Management LP	21,495	$0.41M	0.0%	N/A	0.028%
2/17/2025	Bank of America Corp DE	150,935	$2.84M	0.0%	+9.3%	0.199%
2/17/2025	BNP Paribas Financial Markets	8,700	$0.16M	0.0%	N/A	0.011%
2/17/2025	Ameriprise Financial Inc.	32,152	$0.61M	0.0%	+111.1%	0.042%
2/14/2025	Boxer Capital Management LLC	563,067	$10.61M	0.9%	N/A	0.742%
2/14/2025	RA Capital Management L.P.	1,333,333	$25.12M	0.3%	N/A	1.757%
2/14/2025	Freestone Grove Partners LP	16,724	$0.32M	0.0%	N/A	0.022%
2/14/2025	Schonfeld Strategic Advisors LLC	402,955	$7.59M	0.0%	+13.3%	0.531%
2/14/2025	Darwin Global Management Ltd.	163,681	$3.08M	0.3%	N/A	0.216%
2/14/2025	Northern Trust Corp	659,788	$12.43M	0.0%	+16.4%	0.869%
2/14/2025	The Manufacturers Life Insurance Company	31,025	$0.59M	0.0%	+2.1%	0.041%
2/14/2025	Aquatic Capital Management LLC	4,610	$87K	0.0%	N/A	0.006%
2/14/2025	Virtus ETF Advisers LLC	3,458	$65K	0.0%	-37.3%	0.005%
2/14/2025	Lord Abbett & CO. LLC	437,772	$8.25M	0.0%	+24.8%	0.577%
2/14/2025	Voya Investment Management LLC	55,079	$1.04M	0.0%	+171.8%	0.073%
2/14/2025	T. Rowe Price Investment Management Inc.	2,380,428	$44.85M	0.0%	-6.6%	3.137%
2/14/2025	Price T Rowe Associates Inc. MD	3,007,327	$56.66M	0.0%	-2.0%	3.963%
2/14/2025	Hsbc Holdings PLC	12,107	$0.23M	0.0%	N/A	0.016%
2/14/2025	Tower Research Capital LLC TRC	14,885	$0.28M	0.0%	+422.5%	0.020%
2/14/2025	Teachers Retirement System of The State of Kentucky	26,878	$0.51M	0.0%	-10.5%	0.035%
2/14/2025	MetLife Investment Management LLC	42,539	$0.80M	0.0%	+20.7%	0.056%
2/14/2025	Dimensional Fund Advisors LP	506,839	$9.55M	0.0%	+1.1%	0.668%
2/14/2025	First Trust Advisors LP	135,903	$2.56M	0.0%	N/A	0.179%
2/13/2025	Wasatch Advisors LP	599,401	$11.29M	0.1%	-15.4%	0.790%
2/13/2025	Affinity Asset Advisors LLC	940,083	$17.71M	2.4%	+9.3%	1.239%
2/13/2025	Jump Financial LLC	74,619	$1.41M	0.0%	N/A	0.098%
2/13/2025	Barclays PLC	149,336	$2.81M	0.0%	+16.4%	0.197%
2/13/2025	Summit Investment Advisors Inc.	7,345	$0.14M	0.1%	+13.6%	0.010%
2/13/2025	Kennedy Capital Management LLC	114,623	$2.16M	0.0%	+0.7%	0.151%
2/13/2025	Raymond James Financial Inc.	54,453	$1.03M	0.0%	N/A	0.072%
2/13/2025	Legal & General Group Plc	60,417	$1.14M	0.0%	-7.6%	0.080%
2/13/2025	Invesco Ltd.	51,980	$0.98M	0.0%	-87.4%	0.068%
2/13/2025	ADAR1 Capital Management LLC	11,000	$0.21M	0.0%	N/A	0.014%
2/13/2025	FMR LLC	10,634,231	$200.35M	0.0%	+1,711.9%	14.013%
2/13/2025	Polymer Capital Management HK LTD	50,098	$0.94M	0.2%	N/A	0.066%
2/13/2025	Federated Hermes Inc.	22,640	$0.43M	0.0%	-46.4%	0.030%
2/13/2025	Springhill Fund Asset Management HK Co Ltd	160,500	$3.02M	4.9%	N/A	0.211%
2/13/2025	Russell Investments Group Ltd.	35,745	$0.67M	0.0%	+4,810.0%	0.047%
2/13/2025	Rhenman & Partners Asset Management AB	290,000	$5.46M	0.6%	-3.3%	0.382%
2/13/2025	Wells Fargo & Company MN	39,279	$0.74M	0.0%	-3.7%	0.052%
2/12/2025	ExodusPoint Capital Management LP	85,662	$1.61M	0.0%	+147.5%	0.113%
2/12/2025	Cinctive Capital Management LP	158,972	$3M	0.2%	+51.1%	0.209%
2/12/2025	Bryce Point Capital LLC	28,564	$0.54M	0.2%	N/A	0.038%
2/12/2025	Massachusetts Financial Services Co. MA	67,404	$1.27M	0.0%	-2.9%	0.089%
2/12/2025	Trexquant Investment LP	22,527	$0.42M	0.0%	-85.9%	0.030%
2/12/2025	Geode Capital Management LLC	1,585,127	$29.87M	0.0%	+9.5%	2.089%
2/12/2025	Franklin Resources Inc.	120,445	$2.27M	0.0%	-2.2%	0.159%
2/12/2025	Wellington Management Group LLP	3,586,605	$67.57M	0.0%	+3.0%	4.726%
2/12/2025	Pictet Asset Management Holding SA	1,768,917	$33.33M	0.0%	-1.1%	2.331%
2/12/2025	Norges Bank	318,800	$6.01M	0.0%	N/A	0.420%
2/12/2025	NEOS Investment Management LLC	22,557	$0.43M	0.0%	N/A	0.030%
2/12/2025	JPMorgan Chase & Co.	30,895	$0.58M	0.0%	-54.7%	0.041%
2/11/2025	EntryPoint Capital LLC	14,105	$0.27M	0.1%	N/A	0.019%
2/11/2025	Corebridge Financial Inc.	34,907	$0.66M	0.0%	+2.3%	0.046%
2/11/2025	Vanguard Group Inc.	4,345,266	$81.87M	0.0%	+8.3%	5.726%
2/11/2025	KLP Kapitalforvaltning AS	11,100	$0.21M	0.0%	N/A	0.015%
2/11/2025	Teacher Retirement System of Texas	16,263	$0.31M	0.0%	+18.4%	0.021%
2/10/2025	Primecap Management Co. CA	232,000	$4.37M	0.0%	-20.0%	0.306%
2/10/2025	Nikko Asset Management Americas Inc.	789,222	$14.87M	0.2%	+42.8%	1.040%
2/10/2025	Avalon Trust Co	2,650	$50K	0.0%	-36.1%	0.003%
2/7/2025	Candriam S.C.A.	634,626	$11.96M	0.1%	-40.2%	0.836%
2/6/2025	Raymond James Financial Inc.	54,453	$1.03M	0.0%	N/A	0.072%
2/6/2025	Proficio Capital Partners LLC	19,952	$0.38M	0.0%	N/A	0.026%
2/6/2025	Victory Capital Management Inc.	60,212	$1.13M	0.0%	+179.5%	0.079%
2/6/2025	Charles Schwab Investment Management Inc.	572,834	$10.79M	0.0%	+11.9%	0.755%
2/5/2025	US Bancorp DE	1,424	$27K	0.0%	+144.7%	0.002%

Data available starting January 2016

See Full Table

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and cell therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-2127, an orally bioavailable Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc., Sanofi S.A., and Seagen Inc. co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.

Today's Range

Now: $10.24

$9.52

$10.27

50 Day Range

MA: $13.19

$8.81

$17.59

52 Week Range

Now: $10.24

$8.18

$29.56

Volume

1,322,027 shs

Average Volume

885,096 shs

Market Capitalization

$780.66 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.23

Who are the company insiders with the largest holdings of Nurix Therapeutics?: Nurix Therapeutics' top insider investors include:
Houte Hans Van (CFO)
Gwenn Hansen (Insider)
Christine Ring (Insider)
Christine Ring (General Counsel)
Stefani Wolff (COO)
Learn More about top insider investors at Nurix Therapeutics.
Who are the major institutional investors of Nurix Therapeutics?: Nurix Therapeutics' top institutional investors include:
Rhumbline Advisers — 0.14%
GAMMA Investing LLC — 0.02%
Exchange Traded Concepts LLC — 0.01%
Learn More about top institutional investors of Nurix Therapeutics stock.
Which institutional investors are buying Nurix Therapeutics stock?: During the previous quarter, NRIX stock was bought by institutional investors including:
GAMMA Investing LLC
Rhumbline Advisers
Exchange Traded Concepts LLC